These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23101161)

  • 1. Impact of the 2011 NICE guidance on dementia drugs in a neurology-led memory clinic.
    Larner AJ
    Clin Med (Lond); 2012 Oct; 12(5):496. PubMed ID: 23101161
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinesterase inhibitors and memantine for symptomatic treatment of dementia.
    Rodda J; Carter J
    BMJ; 2012 May; 344():e2986. PubMed ID: 22550350
    [No Abstract]   [Full Text] [Related]  

  • 3. The emperor has no clothes: dementia treatment on the eve of the aging era.
    Royall DR
    J Am Geriatr Soc; 2005 Jan; 53(1):163-4. PubMed ID: 15667396
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of the National Institute for Health and Clinical Excellence and Social Care Institute for Excellence's dementia guidelines in a neurology-led memory clinic.
    Larner AJ
    Clin Med (Lond); 2009 Apr; 9(2):197-8. PubMed ID: 19435136
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of memantine for the treatment of dementia.
    Lo D; Grossberg GT
    Expert Rev Neurother; 2011 Oct; 11(10):1359-70. PubMed ID: 21955192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.
    Wong CW
    Drugs Aging; 2016 Jul; 33(7):451-60. PubMed ID: 27154396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice with antidementia drugs in a geriatric clinic.
    Rungsanpanya T; Muangpaisan W; Praditsuwan R
    J Med Assoc Thai; 2012 Aug; 95(8):1081-9. PubMed ID: 23061314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alarming arbitrariness in EU prescription and reimbursement criteria for anti-dementia drugs.
    Oude Voshaar RC; Burns A; Olde Rikkert MG;
    Int J Geriatr Psychiatry; 2006 Jan; 21(1):29-31. PubMed ID: 16353176
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparing content of dementia care after diagnosis: memory clinics versus general practitioners.
    Meeuwsen EJ; Melis RJ; Meulenbroek O; Rikkert MG;
    Int J Geriatr Psychiatry; 2014 Apr; 29(4):437-8. PubMed ID: 24599734
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological treatment of dementia.
    Schwarz S; Froelich L; Burns A
    Curr Opin Psychiatry; 2012 Nov; 25(6):542-50. PubMed ID: 22992546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When do we discontinue anti-dementia drugs? Views expressed by clinicians in a national survey within the United Kingdom.
    Ray R; Prettyman R
    Int Psychogeriatr; 2013 Sep; 25(9):1559-60. PubMed ID: 23769411
    [No Abstract]   [Full Text] [Related]  

  • 12. What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink.
    Walker VM; Davies NM; Kehoe PG; Martin RM
    Alzheimers Res Ther; 2018 May; 10(1):51. PubMed ID: 29843807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of degenerative dementia disorders--who should be treated?].
    Hasselbalch SG; Kampmann JP
    Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the National Dementia Strategy in a neurology-led memory clinic.
    Larner AJ
    Clin Med (Lond); 2010 Oct; 10(5):526. PubMed ID: 21117401
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.
    O'Brien JT; Holmes C; Jones M; Jones R; Livingston G; McKeith I; Mittler P; Passmore P; Ritchie C; Robinson L; Sampson EL; Taylor JP; Thomas A; Burns A
    J Psychopharmacol; 2017 Feb; 31(2):147-168. PubMed ID: 28103749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication adherence in patients with dementia: an Austrian cohort study.
    Haider B; Schmidt R; Schweiger C; Forstner T; Labek A; Lampl C
    Alzheimer Dis Assoc Disord; 2014; 28(2):128-33. PubMed ID: 24113561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does this patient have Alzheimer disease? Diagnosing and treating dementia.
    Messinger-Rapport BJ
    Cleve Clin J Med; 2003 Sep; 70(9):762, 764, 766-70 passim. PubMed ID: 14518571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing the patient with dementia in long-term care.
    Rhodes-Kropf J; Cheng H; Castillo EH; Fulton AT
    Clin Geriatr Med; 2011 May; 27(2):135-52. PubMed ID: 21641502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic.
    Riordan KC; Hoffman Snyder CR; Wellik KE; Caselli RJ; Wingerchuk DM; Demaerschalk BM
    Neurologist; 2011 Mar; 17(2):121-3. PubMed ID: 21364371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In the Clinic. Dementia.
    Rabins PV; Blass DM
    Ann Intern Med; 2014 Aug; 161(3):ITC1; quiz ITC16. PubMed ID: 25089871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.